CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 513-520

  Kumar, Sudhir ^a   Naqvi, Raza Ali ^a   Ali, Riyasat ^a   Rani, Richa ^b   Khanna, Neena ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Acetylated FoxP3; Leprosy; M. leprae; T regs; Tr1; Ubiquitination

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 10; INTERLEUKIN 2; LYSINE; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; 6,7-DIMETHYL-2-(2E)-3-(1-METHYL-2-PHENYL-1H-PYRROLO(2,3-B)PYRIDIN-3-YL-PROP-2-ENOYL)-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE; CD45 ANTIGEN; CYCLOSPORIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; ISOQUINOLINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ACETYLATION; ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMETHYLATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; LEPROSY; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; REGULATORY T LYMPHOCYTE; STABLE EXPRESSION; UBIQUITINATION; WESTERN BLOTTING; ACTIVE TRANSPORT; ADOLESCENT; ANTAGONISTS AND INHIBITORS; CELL NUCLEUS; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; YOUNG ADULT;

ACETYLATION; ACTIVE TRANSPORT, CELL NUCLEUS; ADOLESCENT; ADULT; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; CYCLOSPORINE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOQUINOLINES; LEPROSY; MALE; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; PYRIDINES; PYRROLES; SMAD3 PROTEIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UBIQUITINATION; YOUNG ADULT;

EID: 84881098266     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.04.015     Document Type: Article

References (28)

1. Anne O' G., Pedro V.L., Paulo V., Anne G.E. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. Journal of Clinical Investigation 2004, 114:1372-1378.
2. Attia E.A., Abdallah M., Saad A.A., Afifi A., EI-Tabbakh A., El-Shennawy D., Ali H.B. Circulating CD4+ CD25 high FoxP3+ T cells vary in different clinical forms of leprosy. International Journal of Dermatology 2010, 49:1152-1158.
3. Bilate A.M., Lafaille J.J. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annual Review of Immunology 2012, 30:733-758.
4. Chattree V., Khanna N., Rao D.N. Alterations in T cell signal transduction by M. leprae antigens is associated with down regulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Molecular Immunology 2007, 44:2066-2077.
5. Chen G.Y., Chen C., Wang L., Chang X., Zheng P., Liu Y. Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology 2008, 15:5163-5166.
6. Chen W., Konkel J.E. TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. Journal of Molecular and Cellular Biology 2010, 2:30-36.
7. Daitoku H., Fukamizu A. FOXO transcription factors in the regulatory networks of longevity. Journal of Biochemistry 2007, 141:769-774.
8. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor FoxP3. Nature Immunology 2005, 6:331-337.
9. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., Zhang H., et al. TGF-beta induces Foxp3+ T-regulatory cells from CD4+CD25-precursors. American Journal of Transplantation 2004, 10:1614-1627.
10. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annual Review of Immunology 2009, 27:313-338.
11. Josefowicz S.Z., Wilson C.B., Rudensky A.Y. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. Journal of Immunology 2009, 1:6648-6652.
12. Kumar S., Naqvi R.A., Khanna N., Rao D.N. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Molecular Immunology 2011, 48:1178-1190.
13. Kumar S., Naqvi R.A., Khanna N., Pathak P., Rao D.N. Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b. Clinical Immunology 2011, 141:133-142.
14. Liston A., Rudensky A.Y. Thymic development and peripheral homeostasis of regulatory T cells. Current Opinion in Immunology 2007, 19:176-185.
15. + regulatory T cells. Nature Immunology 2008, 9:632-640.
16. Naqvi R.A., Hussain A., Raish M., Noor A., Shahid M., Sarin R., Kukreti H., et al. Specific 5'CpG island methylation signatures of FHIT and p16 genes and their potential diagnostic relevance in Indian breast cancer patients. DNA and Cell Biology 2008, 27:517-525.
17. Ottenhoff H., Elferink D.G., Klatser P.R., de Vries R.R. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 1986, 6:462-464.
18. Palermo M.L., Pagliari C., Trindade M.A., Yamashitafuji T.M., Duarte A.J., Cacere C.R., Benard G. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy. American Journal of Tropical Medicine and Hygiene 2012, 86:878-883.
19. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity: a five-group system. International Journal of Leprosy and Other Mycobacterial Diseases 1966, 34:255-273.
20. Romagnani S. Regulation of the T cell response. Clinical and Experimental Allergy 2006, 36:1357-1366.
21. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 2005, 6:345-352.
22. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25 breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995, 1:1151-1164.
23. Scollard D.M., Adams L.B., Gillis T.P., Krahenbuhl J.L., Truman R.W., Williams D.L. The continuing challenges of leprosy. Clinical Microbiology Reviews 2006, 19:338-381.
24. Sridevi K., Khanna N., Chattree V., Pal P.C., Haq W., Rao D.N. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. International Immunopharmacology 2003, 12:1589-1600.
25. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. SMAD3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nature Immunology 2007, 9:194-202.
26. Truman R.W., Singh P., Sharma R., Busso P., Rougemont J., Paniz-Mondolfi A., Kapopoulou A., et al. Probable zoonotic leprosy in the southern United States. New England Journal of Medicine 2011, 364:1626-1633.
27. van Loosdregt J., Vercoulen Y., Guichelaar T., van Gent Y.J., Beekman J., van Beekum O., Brenkman A.B., et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 2010, 115:965-974.
28. Zheng Y., Rudensky A.Y. FoxP3 in control of the regulatory T cell lineage. Nature Immunology 2007, 8:457-462.